Lizzul Paul F., Chief Medical Officer of AnaptysBio ($ANAB), sold shares on the open market four times in the last year for a total of about $522,000. His most recent ANAB sale occurred on January 8, 2026. These transactions rank 6,340th among 11,678 insiders, well below the average sale amount of $8.6 million across 6.4 transactions per insider. He made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2026 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Restricted Stock Unit | 8525 | $0.00 | 25,575.0000 | 27,688,470 | 25.00% | 0.03% |
| Jan. 8, 2026 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | S | Common Stock | 3650 | $44.71 | 42,088.0000 | 27,688,470 | 7.98% | 0.01% |
| Jan. 7, 2026 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Common Stock | 8525 | $0.00 | 45,738.0000 | 27,688,470 | 22.91% | 0.03% |
| Jan. 6, 2026 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | A | Stock Option (right to buy) | 29000 | $0.00 | 29,000.0000 | 27,688,470 | 9999.99% | 0.10% |
| Jan. 7, 2026 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | S | Common Stock | 2235 | $45.11 | 37,213.0000 | 27,688,470 | 5.67% | 0.01% |
| Jan. 6, 2026 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Restricted Stock Unit | 6145 | $0.00 | 6,145.0000 | 27,688,470 | 50.00% | 0.02% |
| Jan. 6, 2026 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | A | Restricted Stock Unit | 21400 | $0.00 | 21,400.0000 | 27,688,470 | 9999.99% | 0.08% |
| Jan. 6, 2026 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Common Stock | 6145 | $0.00 | 39,448.0000 | 27,688,470 | 18.45% | 0.02% |
| Jan. 5, 2026 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | S | Common Stock | 4219 | $43.26 | 33,303.0000 | 27,688,470 | 11.24% | 0.02% |
| Jan. 3, 2026 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Restricted Stock Unit | 10555 | $0.00 | 21,110.0000 | 27,688,470 | 33.33% | 0.04% |
| Jan. 3, 2026 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Common Stock | 10555 | $0.00 | 37,522.0000 | 27,688,470 | 39.14% | 0.04% |
| Dec. 22, 2025 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Employee Stock Option (right to buy) | 1500 | $0.00 | 83,500.0000 | 27,688,470 | 1.76% | 0.01% |
| Dec. 22, 2025 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | S | Common Stock | 1500 | $50.00 | 26,967.0000 | 27,688,470 | 5.27% | 0.01% |
| Dec. 22, 2025 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Common Stock | 1500 | $18.50 | 28,467.0000 | 27,688,470 | 5.56% | 0.01% |
| Jan. 3, 2025 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | F | Common Stock | 4336 | $14.60 | 21,759.0000 | 0 | 16.62% | 0.00% |
| Jan. 3, 2025 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Common Stock | 10555 | $0.00 | 26,095.0000 | 0 | 67.92% | 0.00% |
| Jan. 7, 2025 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | A | Stock Option (right to buy) | 97200 | $0.00 | 97,200.0000 | 0 | 9999.99% | 0.00% |
| Jan. 7, 2025 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | A | Restricted Stock Unit | 34100 | $0.00 | 34,100.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2025 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Restricted Stock Unit | 6145 | $0.00 | 12,290.0000 | 0 | 33.33% | 0.00% |
| Jan. 3, 2025 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Restricted Stock Unit | 10555 | $0.00 | 31,665.0000 | 0 | 25.00% | 0.00% |
| Jan. 6, 2025 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | F | Common Stock | 2261 | $15.30 | 25,643.0000 | 0 | 8.10% | 0.00% |
| Jan. 6, 2025 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Common Stock | 6145 | $0.00 | 27,904.0000 | 0 | 28.24% | 0.00% |
| Sept. 23, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | S | Common Stock | 1500 | $38.67 | 15,398.0000 | 0 | 8.88% | 0.00% |
| Sept. 23, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Common Stock | 1500 | $18.50 | 16,898.0000 | 0 | 9.74% | 0.00% |
| Sept. 23, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Common | 1500 | $0.00 | 85,000.0000 | 0 | 1.73% | 0.00% |
| Sept. 16, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | S | Common Stock | 2220 | $38.93 | 15,398.0000 | 0 | 12.60% | 0.00% |
| Sept. 14, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Common Stock | 6000 | $0.00 | 17,618.0000 | 0 | 51.64% | 0.00% |
| Sept. 14, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Restricted Stock Unit | 6000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | S | Common Stock | 2000 | $40.00 | 11,618.0000 | 0 | 14.69% | 0.00% |
| Aug. 14, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Common | 2000 | $0.00 | 86,500.0000 | 0 | 2.26% | 0.00% |
| Aug. 14, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Common Stock | 2000 | $18.50 | 13,618.0000 | 0 | 17.21% | 0.00% |
| July 22, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | A | Common Stock | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| July 18, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Common | 1500 | $0.00 | 88,500.0000 | 0 | 1.67% | 0.00% |
| July 18, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | S | Common Stock | 1500 | $35.00 | 11,618.0000 | 0 | 11.43% | 0.00% |
| July 18, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Common Stock | 1500 | $18.50 | 13,118.0000 | 0 | 12.91% | 0.00% |
| Jan. 6, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Restricted Stock Unit | 6145 | $0.00 | 18,435.0000 | 0 | 25.00% | 0.00% |
| Jan. 6, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Common Stock | 6145 | $0.00 | 12,672.0000 | 0 | 94.15% | 0.00% |
| Jan. 8, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | S | Common Stock | 2554 | $21.81 | 10,118.0000 | 0 | 20.15% | 0.00% |
| Jan. 3, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | A | Restricted Stock Unit | 42220 | $0.00 | 42,220.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2024 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | A | Stock Option (right to buy) | 115540 | $0.00 | 115,540.0000 | 0 | 9999.99% | 0.00% |
| Sept. 14, 2023 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Restricted Stock Unit | 6000 | $0.00 | 6,000.0000 | 0 | 50.00% | 0.00% |
| Sept. 14, 2023 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | M | Common Stock | 6000 | $0.00 | 8,632.0000 | 0 | 227.96% | 0.00% |
| Sept. 14, 2023 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | S | Common Stock | 2105 | $19.48 | 6,527.0000 | 0 | 24.39% | 0.00% |
| Jan. 6, 2023 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | A | Restricted Stock Unit | 24580 | $0.00 | 24,580.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2023 | ANAPTYSBIO, INC | $ANAB | Lizzul Paul F. | Chief Medical Officer | A | Stock Option (right to buy) | 67070 | $0.00 | 67,070.0000 | 0 | 9999.99% | 0.00% |